Number of patients |
102 |
Paris hospital |
44 |
Toulouse hospital |
58 |
Men, n (%) |
36 (35) |
Age at first symptom, mean (SD) |
35.9 ± 23.8 |
Age at diagnosis, mean (SD) |
39.4 ± 18.5 |
Age at first neuropsychological assessment, mean (SD) |
43 ± 13 |
Years of study, median (IQ) |
11 (11–14) |
Delay first symptom/diagnosis (day), median (IQ) |
68 (0–497) |
Ethnicity, n (%) |
Caucasian |
72 (70) |
North African |
12 (12) |
Asian |
10 (10) |
Other |
8 (8) |
Moyamoya angiopathy subtype, n (%) |
MMA disease |
64 (63) |
MMA syndrome |
38 (37) |
Bilateral MMA |
63 (62) |
Family history, n (%) |
2 (2) |
Clinical presentation, n (%) |
All strokes |
63 (62) |
Ischemic stroke |
48 (47) |
Hemorrhagic stroke |
15 (14) |
TIA |
11(10) |
Headache |
10 (9) |
Incidental |
17 (16) |
Epilepsy |
1 (1) |
Vascular risk factors, n (%) |
Hypertension |
30 (29) |
Smoking |
37 (36) |
Dyslipidemia |
22 (22) |
Imaging characteristics, n (%) |
Presence of transdural anastomosis |
21 (21) |
Vertebro-basilar involvement |
16 (16) |
Presence of one or more ischemic lesions |
75 (74) |
Presence of one or more hemorrhagic lesions |
16 (16) |